These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 23916269)

  • 1. [Pharmacological therapy of temporomandibular joint pain].
    Hugger A; Schindler HJ; Türp JC; Hugger S
    Z Evid Fortbild Qual Gesundhwes; 2013; 107(4-5):302-8. PubMed ID: 23916269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain.
    Marini I; Bartolucci ML; Bortolotti F; Gatto MR; Bonetti GA
    J Orofac Pain; 2012; 26(2):99-104. PubMed ID: 22558609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuro-reflexotherapy for the management of myofascial temporomandibular joint pain: a double-blind, placebo-controlled, randomized clinical trial.
    Berguer A; Kovacs F; Abraira V; Mufraggi N; Royuela A; Muriel A; Gestoso M; Falahat F; Martín-Granizo R; Zamora J
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1664-77. PubMed ID: 18634956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical versus systemic diclofenac in the treatment of temporo-mandibular joint dysfunction symptoms.
    Di Rienzo Businco L; Di Rienzo Businco A; D'Emilia M; Lauriello M; Coen Tirelli G
    Acta Otorhinolaryngol Ital; 2004 Oct; 24(5):279-83. PubMed ID: 15871609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronized palmitoylethanolamide reduces joint pain and glial cell activation.
    Bartolucci ML; Marini I; Bortolotti F; Impellizzeri D; Di Paola R; Bruschetta G; Crupi R; Portelli M; Militi A; Oteri G; Esposito E; Cuzzocrea S
    Inflamm Res; 2018 Oct; 67(10):891-901. PubMed ID: 30121836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trigger point injection therapy in the management of myofascial temporomandibular pain.
    Ozkan F; Cakır Özkan N; Erkorkmaz U
    Agri; 2011 Jul; 23(3):119-25. PubMed ID: 21935818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.
    Esposito E; Cuzzocrea S
    Mini Rev Med Chem; 2013 Feb; 13(2):237-55. PubMed ID: 22697514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results].
    Lo Monte G; Soave I; Marci R
    Minerva Ginecol; 2013 Aug; 65(4):453-63. PubMed ID: 24051945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piroxicam and laser phototherapy in the treatment of TMJ arthralgia: a double-blind randomised controlled trial.
    de Carli ML; Guerra MB; Nunes TB; di Matteo RC; de Luca CE; Aranha AC; Bolzan MC; Witzel AL
    J Oral Rehabil; 2013 Mar; 40(3):171-8. PubMed ID: 23252583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vulvodynia and proctodynia treated with topical baclofen 5 % and palmitoylethanolamide.
    Keppel Hesselink JM; Kopsky DJ; Sajben NL
    Arch Gynecol Obstet; 2014 Aug; 290(2):389-93. PubMed ID: 24691823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Myoarthropathy of the temporomandibular joint and masticatory muscles. Pain therapy management and relaxation instead of aggressive surgery].
    Türp JC
    MMW Fortschr Med; 2003 May; 145(19):33-5. PubMed ID: 12813975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palmitoylethanolamide in the treatment of chronic pain caused by different etiopathogenesis.
    Gatti A; Lazzari M; Gianfelice V; Di Paolo A; Sabato E; Sabato AF
    Pain Med; 2012 Sep; 13(9):1121-30. PubMed ID: 22845893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The feasibility of a clinical trial of pain related to temporomandibular muscle and joint disorders: the results of a survey from the Collaboration on Networked Dental and Oral Research dental practice-based research networks.
    Velly AM; Schiffman EL; Rindal DB; Cunha-Cruz J; Gilbert GH; Lehmann M; Horowitz A; Fricton J
    J Am Dent Assoc; 2013 Jan; 144(1):e1-10. PubMed ID: 23283934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of temporomandibular disorders.
    Dym H; Israel H
    Dent Clin North Am; 2012 Jan; 56(1):149-61, ix. PubMed ID: 22117948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical NSAIDs for joint disease.
    Drug Ther Bull; 1999 Nov; 37(11):87-8. PubMed ID: 10696693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging neuroprotective effects of N-palmitoylethanolamide besides its significant antinociceptive effects.
    Kapoor S
    Pain Med; 2013 May; 14(5):773-4. PubMed ID: 23581707
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of systemic versus topical nonsteroidal anti-inflammatory drugs on postexercise jaw-muscle soreness: a placebo-controlled study.
    Svensson P; Houe L; Arendt-Nielsen L
    J Orofac Pain; 1997; 11(4):353-62. PubMed ID: 9656912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area.
    Winocur E; Gavish A; Halachmi M; Eli I; Gazit E
    J Orofac Pain; 2000; 14(1):31-6. PubMed ID: 11203735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis treatment with ultramicronized palmitoylethanolamide: a case report.
    Clemente S
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):933-6. PubMed ID: 22998138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical applications of palmitoylethanolamide in pain management: protocol for a scoping review.
    Passavanti MB; Alfieri A; Pace MC; Pota V; Sansone P; Piccinno G; Barbarisi M; Aurilio C; Fiore M
    Syst Rev; 2019 Jan; 8(1):9. PubMed ID: 30621775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.